Method of using calcilytic compounds

US6022894A · kind A · utility

Assignees

• NPS PHARMACEUTICALS, INC. · US
• SmithKline Beecham Limited · US
• SmithKline Beeacham P.L.C. · GB

Inventors

• Eric G. Del Mar · Salt Lake City, US
• Robert M. Barmore · Salt Lake City, US
• Derek James Sheehan · Galesburg, US
• Bradford C. Van Wagenen · Salt Lake City, US
• James Francis Callahan · Philadelphia, US
• Richard M. Keenan · Malvern, US
• Nikesh R. Kotecha · Thurmaston, GB
• Maria Amparo Lago · Audubon, US
• Linda Sue Southall · West Chester, US
• Mervyn Thompson · Harlow, GB

Key dates

• Filing date: Apr 4, 1997
• Grant date: Feb 8, 2000
• Expiry date: Apr 4, 2017

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2603/74
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention features calcilytic compounds. "Calcilytic compounds" refer to compounds able to inhibit calcium receptor activity. Also described are the use of calcilytic compounds to inhibit calcium receptor activity and/or achieve a beneficial effect in a patient; and techniques which can be used to obtain additional calcilytic compounds.